1. Home
  2. HP vs VCYT Comparison

HP vs VCYT Comparison

Compare HP & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helmerich & Payne Inc.

HP

Helmerich & Payne Inc.

HOLD

Current Price

$34.55

Market Cap

3.2B

Sector

Energy

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$38.97

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HP
VCYT
Founded
1920
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
HP
VCYT
Price
$34.55
$38.97
Analyst Decision
Hold
Strong Buy
Analyst Count
12
8
Target Price
$32.58
$46.50
AVG Volume (30 Days)
2.0M
750.6K
Earning Date
05-04-2026
05-25-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
130.39
EPS
N/A
0.32
Revenue
$3,746,013,000.00
N/A
Revenue This Year
$9.32
$11.95
Revenue Next Year
$2.44
$11.97
P/E Ratio
N/A
$111.63
Revenue Growth
35.89
N/A
52 Week Low
$14.65
$22.61
52 Week High
$36.73
$50.71

Technical Indicators

Market Signals
Indicator
HP
VCYT
Relative Strength Index (RSI) 54.14 55.82
Support Level $31.94 $37.98
Resistance Level $36.43 $46.24
Average True Range (ATR) 1.45 1.47
MACD -0.17 0.37
Stochastic Oscillator 55.48 84.06

Price Performance

Historical Comparison
HP
VCYT

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Share on Social Networks: